语言

China

中国 地图

查看印度查看巴西

省份

请在下方的农业企业信息库中进行搜索

行业

位置: 中国 - Jiangsu - 行业- - CRYSTAL PHARMATECH

  • 公司名称: CRYSTAL PHARMATECH

  • 联系人:

  • 电话:

  • 行业: 实验室 Laboratory

  • 地址: 8/9F, 288 Jiangyun Road, Suzhou Industrial Park Suzhou, Jiangsu, 215123 China

  • E-mail:

  • Company category:

  • 员工数量:

  • 网站地址:

  • Last updated: 2026-03-23

纳税人编号:

营收:

公司介绍 ：

From Molecule to Medicine—Your Partner in Small Molecules, Biologics, and Nucleic Acids Crystal Pharmatech, founded in 2010, is a global contract research organization with over 300 employees and four R&D centers in New Jersey (USA), San Francisco (USA), Toronto (Canada), and Suzhou (China). Collectively, these sites provide integrated support for pharmaceutical and biotechnology companies worldwide. Our capabilities span three specialized platforms: in small molecules, we offer API solid-state research and crystallization, preformulation, formulation development, and GMP manufacturing and supply; through Crystal Bio Solutions, we deliver bioanalytical and biomarker testing, biologics CMC analytics, and quantitative clinical pharmacology; and through Crystal NAX, we provide end-to-end solutions for nucleic acid therapeutics. With an average of 20 years of experience, our scientific leadership team has successfully delivered over 100 NCEs and 15 drug products for global pharmaceutical companies. We have served more than 1,000 clients, supporting over 2,000 new chemical entities. Crystal Pharmatech (In Small Molecules) — Global Leader in Solid-State Research, Preformulation & Formulation We offer solid-state research, preformulation, and formulation of small-molecule drugs. We have supported 1,000+ clients and worked on more than 2,000 compounds across developability assessment, solid-form screening, preformulation, formulation development, and clinical trial materials (CTM) through to commercial manufacturing. With four R&D centers in New Jersey, California, Toronto, and Suzhou, and a team of approximately 300 professionals, we combine deep crystal-form expertise with both conventional and enabling technologies—such as amorphous solid dispersion—to unlock bioavailability and manufacturability. Our cGMP facilities operate to FDA, EMA, and NMPA standards, ensuring phase-appropriate quality from early studies through scale-up. Leveraging our unique expertise, we partner with you to design and develop the most suitable crystal form and formulation for downstream development. Our guiding principle—“get the crystal form and formulation right the first time for Phase I”—accelerates IND filing and Phase I entry while minimizing the need for human pharmacokinetic (PK) bridging studies, saving time and reducing costs as programs advance to Phase II and beyond. Crystal Bio Solutions — Your Trusted Partner for Biologics CMC Analytical, Bioanalysis & QCP Crystal Bio Solutions (wholly owned) delivers Quantitative Clinical Pharmacology (QCP), Bioanalytical & Biomarker, and Biologics CMC Analytical services. Modalities include antibodies, bispecifics and multispecifics, proteins, ADCs, cell and gene therapies (CGT), mRNA, LNPs, nucleotides, vaccines, and viruses—providing decision-ready data through sound science and operational excellence. Crystal NAX — Unlocking the Potential of Nucleic Acid Therapeutics Crystal NAX (wholly owned) provides end-to-end support for nucleic acid therapeutics—from early R&D to clinical development—covering xRNA, siRNA, and other oligonucleotides; LNP delivery and formulation; and advanced analytics. Its mission is to accelerate innovation in nucleic acid therapies and help deliver medicines to patients faster. Together, Crystal Pharmatech offers a seamless path from discovery to clinic for small molecules, biologics, and nucleic acids—your partner of choice from molecule to medicine.

公司产品：